The primary regulatory bodies involved in approving treatments for neonatal disorders include the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national regulatory agencies. These agencies have specialized divisions that focus on pediatric and neonatal care, ensuring that the unique needs of this population are addressed.
